您的位置: 首页 > 农业专利 > 详情页

Recombinant Vectors Based on the Modified Ankara Virus (MVA) as Preventive and Therapeutic Vaccines against AIDS
专利权人:
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
发明人:
HEENEY, JONATHAN,MOOIJ, PETRA,GOMEZ RODRIGUEZ, CARMEN ELENA,NAJERA GARCIA, JOSE LUIS,JIMENEZ TENTOR, VICTORIA,ESTEBAN RODRIGUEZ, MARIANO
申请号:
DK06778467
公开号:
DK1921146T3
申请日:
2006.07.25
申请国别(地区):
DK
年份:
2012
代理人:
摘要:
Recombinant vector (A) derived from modified Ankara virus (MVA) that expresses simultaneously (i) a form of the Env protein of HIV-1 that lacks the region corresponding to the whole of gp41 and (ii) a fusion protein (FP) containing sequences of the Gag, Pol and Nef genes of HIV-1, where the sequences encoding (i) and (ii) are under control of identical promoters and are inserted into the same site in the vector. Independent claims are included for the following: (1) similar vector (A1) in which FP and the Gag-Pol-Nef fusion are from simian immune deficiency virus (SIV); (2) recombinant vector (A2) derived from NYVAC virus having the same genomic organization, insertion sites and promoters as (A1); and (3) plasmid (P) used as intermediate for construction and/or characterization of (A1). ACTIVITY : Ant-HIV. No details of tests for anti-HIV activity are given. MECHANISM OF ACTION : Vaccine.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充